Active in over 25 countries
Cutting-edge global biotech development & production of affordable medication worldwide
Message from our founder/ceo - DR. ANTHONY OSEI BOATENG
CALL TO ACTION
I began this London-based Biotech start-up with the vision of a world in which medication and treatments would be affordable, easily accessible, gene-specific and tailored to the specified needs of patients.
Happy!! to announce that in Q4 2022 An & An Global was officially appointed as Consultants for a $44m USD Pharmaceutical Factory development in Ethiopia and a $30m USD pharma / vaccine manufacturing plant development in Senegal.
Happy!! to announce the approval of An & An Global Malaria and HIV test kits by Ghana FDA in West Africa on 7th February, 2022 (certificates available upon request).
An & An Global is currently ACTIVE IN OVER 25 COUNTRIES GLOBALLY and believes in collective global efforts for solving global healthcare problems. We believe that our diversity makes us stronger hence, we are keen to hear from institutions, scientists, and collaborators with interests aligned to ours for mutually-beneficial cooperation.
GLOBAL CONSULTANTS FOR ESTABLISHING & EQUIPPING HOSPITALS, PHARMA & BIOCHEMICAL MANUFACTURING PLANTS
An & An Global is an expert you can count on in establishing and sourcing equipment for hospitals, pharmaceutical and biochemical manufacturing plants worldwide. In 2022, An & An Global was officially appointed as Consultants for a $44m USD Pharmaceutical Factory development in Ethiopia and a $30m USD pharma / vaccine manufacturing plant development in Senegal.
We have a pool of experts in over 25 countries ready to assist with your query and are very hands-on in helping industries reach and exceed their full potential.
MEDICAL DEVICES - (MALARIA, HIV, COVID-19 LATERAL FLOW TESTS, MED-FIT VAGUS NERVE STIMULATORS ETC)
An & An Global is involved in the global distribution of HIV, Malaria, COVID-19 lateral flow, Med-Fit TENS & Vagus Nerve stimulator pain management devices (exclusive distributor for Africa) and many more.
We are helping in the fight against COVID-19 by aiding in the development and distribution of COVID-19 lateral flow test kits in Europe, Africa and Asia. We ensure that our clients are provided with highly sensitive, specific and state of the art lateral flow test kits. We have our in-house An & An Global test kits and also authorised distributors for Sona Nanotech.
GLOBAL MEDICAL DEVICE REGISTRATION, REGULATORY & RESEARCH CONSULTATION
We have excellent expertise on the requirements of regulatory bodies (especially in Europe and Africa) for the registration and regulation of medical devices and medications by offering consultancy services in this regard to companies seeking to get their products approved by global (especially African) regulatory bodies .
As part of our efforts to facilitate knowledge transfer and advanced research, we provide research consultation for researchers across the globe in a broad array of subjects. If you're a researcher with pressing issues requiring a solution, don't hesitate to contact us using the contact form at the bottom of this page or by pressing the (yellow and black) chat box and we will be in touch immediately.
COVID-19 IN-STORE NAVIGATION / SOCIAL-DISTANCING
An & An Biotech is responding to COVID-19 by working with our partners on a system which indicates the number of shoppers in-store at any given point in time and help customers to avoid overcrowding. As a bonus, this system will also tell customers the location of in-store items and their stock levels to avoid unnecessary movements around the shops and also save time spent shopping.
This new venture is proceeding rapidly hence we are keen to hear from companies and collaborators who would like form part of our trial zones.
PHARMACOGENOMIC MODULES
One of the key focal areas of An & An Global is developing pharmacogenomic modules which will enable Doctors to prescribe medication to patients based on their genetic outlook, hence minimising side-effects as much as possible.
Our current focus is on beta-blocker anti-hypertensives and anti-cholesterol statins. A research conducted in the UK on 165,000 patients and reported on the BBC highlighted limited effectiveness of statins in 50% of subjects treated. With gene-specific prescriptions of statins, this percentage could be increased significantly.
GLOBAL PRODUCTION AND SUPPLY OF HIGH QUALITY AFFORDABLE MEDICINE AND NATURAL WELLNESS PRODUCTS
We have a strong belief that high quality medication should be affordable especially for low income families in developing countries. This can be made possible via cutting-edge technology and know-how. An & An Global is passionate about using our technical and financial resources to help in the production and supply of affordable medicines and natural wellness products globally.
Our current focus is on Africa, Asia and Middle East. You can read more about one of such projects which we are facilitating in the projects section. We welcome collaborators who share this dream and passion with interest in beginning a similar venture in other parts o the world with us.
We are supported by
